A detailed history of Deseret Mutual Benefit Administrators transactions in Eli Lilly & CO stock. As of the latest transaction made, Deseret Mutual Benefit Administrators holds 3,302 shares of LLY stock, worth $2.94 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares
3,302
Previous 3,246 1.73%
Holding current value
$2.94 Million
Previous $2.53 Million 18.38%
% of portfolio
1.39%
Previous 1.27%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$724.87 - $909.04 $40,592 - $50,906
56 Added 1.73%
3,302 $2.99 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $110,741 - $148,156
187 Added 6.11%
3,246 $2.53 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $476,872 - $562,170
-908 Reduced 22.89%
3,059 $1.78 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $145,189 - $200,166
-334 Reduced 7.77%
3,967 $2.13 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $53,663 - $71,753
153 Added 3.69%
4,301 $2.02 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $12,735 - $14,957
-41 Reduced 0.98%
4,148 $1.42 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $981,049 - $1.14 Million
-3,051 Reduced 42.14%
4,189 $1.53 Million
Q3 2022

Nov 03, 2022

SELL
$296.48 - $337.87 $390,167 - $444,636
-1,316 Reduced 15.38%
7,240 $2.34 Million
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $109,262 - $128,289
392 Added 4.8%
8,556 $2.77 Million
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $493,553 - $613,360
-2,103 Reduced 20.48%
8,164 $2.34 Million
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $349,416 - $433,628
1,554 Added 17.84%
10,267 $2.84 Million
Q3 2021

Nov 04, 2021

BUY
$221.6 - $272.71 $1.47 Million - $1.81 Million
6,629 Added 318.09%
8,713 $2.01 Million
Q2 2021

Aug 06, 2021

BUY
$180.55 - $233.54 $376,266 - $486,697
2,084 New
2,084 $478,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $847B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Deseret Mutual Benefit Administrators Portfolio

Follow Deseret Mutual Benefit Administrators and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deseret Mutual Benefit Administrators, based on Form 13F filings with the SEC.

News

Stay updated on Deseret Mutual Benefit Administrators with notifications on news.